Metronidazole-resistant H pylori--of questionable clinical importance

Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests.

Gut·1997

Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.

Alimentary pharmacology & therapeutics·1996

Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer.

Alimentary pharmacology & therapeutics·1995

Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH.

Gut·1995

Rising death rate from non-malignant disease of the oesophagus (NMOD) in England and Wales.

Gut·1995

Optimizing acid suppression for treatment of acid-related diseases.

Digestive diseases and sciences·1995

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Fluoroquinolone-resistant <i>Salmonella Typhi</i> presenting as ileal perforation in a traveler.

Journal of surgical case reports·2026

Teclistamab in relapsed/refractory Waldenstro m macroglobulinemia.

Haematologica·2026

Human granulocytic anaplasmosis-associated myopericarditis: a case report and literature review of a treatable cause of myopericarditis.

Journal of medical case reports·2026

Pagetoid reticulosis (Woringer-Kolopp disease) mimicking eczema: a case report with immunophenotypic analysis and literature review.

Frontiers in immunology·2026

[Pleural Well-differentiated Papillary Mesothelial Tumor Presenting with  Recurrent Pneumothorax and Pleural Effusion: A Case Report].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2026

Anthracofibrosis: an under-recognised mimic of malignancy and tuberculosis in a migrant population.

Internal medicine journal·2026

Related Experiment Videos

Metronidazole-resistant H pylori--of questionable clinical importance

Related Concept Videos

Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests.

Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.

Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer.

Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH.

Rising death rate from non-malignant disease of the oesophagus (NMOD) in England and Wales.

Optimizing acid suppression for treatment of acid-related diseases.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Fluoroquinolone-resistant <i>Salmonella Typhi</i> presenting as ileal perforation in a traveler.

Teclistamab in relapsed/refractory Waldenstro m macroglobulinemia.

Human granulocytic anaplasmosis-associated myopericarditis: a case report and literature review of a treatable cause of myopericarditis.

Pagetoid reticulosis (Woringer-Kolopp disease) mimicking eczema: a case report with immunophenotypic analysis and literature review.

[Pleural Well-differentiated Papillary Mesothelial Tumor Presenting with  Recurrent Pneumothorax and Pleural Effusion: A Case Report].

Anthracofibrosis: an under-recognised mimic of malignancy and tuberculosis in a migrant population.

Related Experiment Videos

Metronidazole-resistant H pylori--of questionable clinical importance

Related Concept Videos

Related Articles